001     167755
005     20240229133547.0
024 7 _ |a 10.1161/HYPERTENSIONAHA.120.16354
|2 doi
024 7 _ |a pmid:33641358
|2 pmid
024 7 _ |a 0194-911X
|2 ISSN
024 7 _ |a 0362-4323
|2 ISSN
024 7 _ |a 1524-4563
|2 ISSN
024 7 _ |a altmetric:101230590
|2 altmetric
037 _ _ |a DKFZ-2021-00519
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Vishram-Nielsen, Julie K K
|b 0
245 _ _ |a Predictive Importance of Blood Pressure Characteristics With Increasing Age in Healthy Men and Women: The MORGAM Project.
260 _ _ |a Baltimore, Md.
|c 2021
|b Williams & Wilkins
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1637230529_29975
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2021 Apr;77(4):1076-1085
520 _ _ |a It remains unclear which blood pressure (BP) characteristics best predict cardiovascular risk in different age groups and between sexes. We leveraged data from the MORGAM (MONICA [Monitoring of Trends and Determinants in Cardiovascular Disease], Risk, Genetics, Archiving and Monograph) Project to investigate determinants of BP characteristics and their prognostic importance, in younger and older (
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a blood pressure
|2 Other
650 _ 7 |a cardiovascular disease
|2 Other
650 _ 7 |a myocardial infarction
|2 Other
650 _ 7 |a prognosis
|2 Other
650 _ 7 |a risk factor
|2 Other
700 1 _ |a Kristensen, Anna M Dyrvig
|b 1
700 1 _ |a Pareek, Manan
|b 2
700 1 _ |a Laurent, Stephane
|b 3
700 1 _ |a Nilsson, Peter M
|b 4
700 1 _ |a Linneberg, Allan
|b 5
700 1 _ |a Greve, Sara V
|b 6
700 1 _ |a Palmieri, Luigi
|b 7
700 1 _ |a Giampaoli, Simona
|b 8
700 1 _ |a Donfrancesco, Chiara
|b 9
700 1 _ |a Kee, Frank
|b 10
700 1 _ |a Mancia, Giuseppe
|b 11
700 1 _ |a Cesana, Giancarlo
|b 12
700 1 _ |a Veronesi, Giovanni
|b 13
700 1 _ |a Grassi, Guido
|b 14
700 1 _ |a Kuulasmaa, Kari
|b 15
700 1 _ |a Salomaa, Veikko
|b 16
700 1 _ |a Palosaari, Tarja
|b 17
700 1 _ |a Sans, Susana
|b 18
700 1 _ |a Ferrieres, Jean
|b 19
700 1 _ |a Dallongeville, Jean
|b 20
700 1 _ |a Söderberg, Stefan
|b 21
700 1 _ |a Moitry, Marie
|b 22
700 1 _ |a Drygas, Wojciech
|b 23
700 1 _ |a Tamosiunas, Abdonas
|b 24
700 1 _ |a Peters, Annette
|b 25
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 26
|u dkfz
700 1 _ |a Grimsgaard, Sameline
|b 27
700 1 _ |a Savallampi, Matti
|b 28
700 1 _ |a Olsen, Michael H
|b 29
700 1 _ |a Project†, MORGAM
|b 30
|e Collaboration Author
773 _ _ |a 10.1161/HYPERTENSIONAHA.120.16354
|0 PERI:(DE-600)2094210-2
|n 4
|p 1076-1085
|t Hypertension
|v 77
|y 2021
|x 1524-4563
909 C O |p VDB
|o oai:inrepo02.dkfz.de:167755
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 26
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
913 0 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2021
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
|d 2021-01-30
|w ger
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2021-01-30
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b HYPERTENSION : 2019
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-01-30
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b HYPERTENSION : 2019
|d 2021-01-30
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21